Redefining the Future of Healthcare with an MBA in Pharmaceutical Management at NMIMS
India has emerged as a prominent destination for medical tourism. This is mainly due to its affordable healthcare, which is supported by advanced technology and significant reforms. Additionally, India is known as the “Pharmacy of the World,” as its pharmaceuticals are highly sought after for their cost-effectiveness and quality.
Moreover, India benefits from lower manufacturing costs, approximately 30% to 35% less than those in the US and Europe. In terms of economic research and development expenses, they are about 87% lower than those in developed nations. Consequently, this creates a demand for skilled professionals who can work at competitive rates.
These trends indicate that the healthcare industry is on an upward trajectory. As a result, there is an increasing need for trained pharmaceutical professionals who understand the business’s intricate aspects and possess strong leadership potential. Recognising this demand, NMIMS is offering an MBA in Pharmaceutical Management. For more details, explore this blog.
What are the unique course offerings?
SVKM’s NMIMS School of Business Management (NMIMS): MBA(Pharmaceutical Management)
NMIMS offers a two-year full-time MBA (Pharmaceutical Management) designed for those pursuing careers in the pharmaceutical industry. It prepares students for various roles in pharmaceuticals, medical devices, market research, and healthcare IT, typically leading to careers in sales, marketing, business analysis, and project management.
Below are the program highlights that detail the course methodologies used to equip students.
Program Highlights
| Features | Description |
| Domain Specific Courses | Taught by functional heads from the industry. |
| Consumer Research | 180+ hours of fieldwork, 100+ hours of data analysis. |
| Alumni Connection | Alumni contributing to industry growth. |
| Strategic Brand Marketing Plan | Brand research projects conducted by students nearing graduation. |
| Summer Internship | 8 weeks of industry exposure through Internship. |
| CEO/HR Expert Forum | Speaker events on industry business topics. |
| Industry Award | Students annually receive industry-sponsored gold and silver medals for academic excellence. |
| Case Studies | Examples from leading business schools globally, like Harvard, Kellogg, and INSEAD, and case studies from India’s pharmaceutical sector. |
Curriculum Overview
The first three semesters total 60 credits, covering 26 courses and an additional course. The second trimester provides 45 credits across 24 courses. This program incorporates a variety of teaching methods, including lectures, case discussions (primarily utilising Harvard and Indian cases developed by faculty), live experiential learning opportunities, workshops, role-playing exercises, video discussions, and fieldwork, all aimed at enhancing knowledge and skills.
After completing the first term, all students must complete 8-week internships in relevant industries.
| Trimester I | Trimester II | Trimester III | |
| Credits | 21 | 21 | 18 |
| Compulsory Workshops | Basics of Anatomy, Physiology and Pathology( 06 hours workshop)
Basics of Pharmacology (06 hours workshop) Interview Skills (03 hours workshop) |
Pharma Sales Communication (Situational Role Plays) ( 06 hours workshop) | New Division Planning ( 06 hours workshop)
Workshop on R (06 hours workshop) |
| Trimester IV | Trimester V | Trimester VI | |
| Credits | 16.5 | 16.5 | 12 |
| Compulsory Workshops | Brand Promotion Story and Support Development (06 hours workshop) | Marketing Strategy Simulation (Compulsory 12 hours workshop) | Indian Management Thoughts and Ethos (Compulsory 06 hours workshop) |
Placement Highlights for the Class of 2024
The following table summarises the key placement statistics for the graduating class of 2024, highlighting the cohort’s diversity and success.
Placement Statistics
| Category | Details |
| Batch Size | 97 |
| Gender Distribution | Male: 49%, Female: 51% |
| Highest Package | 25 Lakh Per Annum |
| Average Package | 10.40 Lakh Per Annum |
The table below outlines the distribution of placements across various industries and the profiles available to MBA Pharmaceutical graduates.
Industry Overview and Profile Distribution
| Industry Wise Distribution | Profile Offered |
| Pharmaceuticals | Sales & Marketing |
| Consulting & Market Research | Consulting |
| Medical Devices | Project Management |
| Diagnostics | Client Servicing |
| Healthcare Communications | International Marketing |
| Nutraceuticals | Operations |
| Business Development |
Here is an overview of the recruiters who participated in the placement process for the 2024 batch. This year’s placements showcased a diverse array of companies from various sectors, each offering unique opportunities to shape the professional journeys of graduates. The recruiters included a mix of innovative startups and well-known industry giants, highlighting the wide range of skills and talents present in the graduating class.
Participating Recruiters for Batch 2024
| Industry | Company Name(s) |
| Pharmaceuticals | Abbott, AbbVie, Ajanta Pharma (AP), Alembic, Alkem, AstraZeneca, Boehringer Ingelheim, Cadila Pharmaceuticals, Cipla, Macleods, Micro Labs Limited, MSD, Novartis, Neuland, Novo Nordisk, PharmaACE, Piramal, Roche, Sun Pharma, Torrent Pharmaceuticals, USV, Viatris, Zydus Lifesciences |
| Medical Devices | Boston Scientific, Medtronic, Medulla, Smith & Nephew, Terumo, Zimmer Biomet |
| Consulting/Market Research | Aranca, Blue Matter, Cognizant, CRISIL, Michael Page, Optum, PwC, Smart Cube, ZS Associates |
| Healthcare Services | BioPlus, Cetas Healthcare, Curatio, Medtrix, Suburban Diagnostics, Syneos Health |
| Biotechnology | Biocon |
| Infant Nutrition | Neolacta |
| Scientific Instruments/Services | Thermo Fisher Scientific |
| IT Services | TCS, Tech Mahindra |
| Others | AR, Meyer, S Insights, Servier, SMSRC, Sunyata Romadis, Voll Sante |
Growth Forecasts for the Indian Healthcare Industry
The Indian pharmaceutical sector is projected to grow significantly, with an estimated market size of US$130 billion by 2030 and expected to reach US$450 billion by 2047. This sector is crucial for foreign trade in India and offers strong investment opportunities. India is a top provider of affordable generic medications. Many manufacturing facilities meet WHO and USFDA standards.
Moreover, the market for medicines is set to grow by 9-12% over the next five years. This growth will place India among the top 10 countries in pharmaceutical spending.
Additionally, future growth will depend on how companies adapt their products. They need to focus on rising chronic diseases like cardiovascular issues, diabetes, depression, and cancer.
Furthermore, government initiatives will support the industry. The National Health Protection Scheme aims to provide universal healthcare, and efforts to offer low-cost generic drugs will also help.
Overall, these trends create promising prospects for MBA graduates in Pharmaceutical Management.
